Altos Co-founder and Chief Scientist Rick Klauns
Author: Michael
The OSCE Parliamentary Assembly endorses longevi
Amyloid plaque-targeting therapy to be marketed
Swiss company builder demonstrates that a focus
Partnership combines advanced precision medicine
Longevity Investors Conference returns to Switze
Alden Scientific CEO on creating a GPS for longe
CIRM funding will support the company through IN
Radio frequency technology that shows promise in
TruDiagnostic launches SYMPHONYAge, the first ev